Navigation Links
Biodefense Industry Response to New WMD Report Card
Date:1/26/2010

ANNAPOLIS, Md., Jan. 26 /PRNewswire-USNewswire/ -- The following is a statement by David Wright, President and CEO of PharmAthene, regarding the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism Report Card:

Today's Report Card by the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism sends a dire warning that America still remains vulnerable to bioterrorism.  Our Nation's ability to prevent and respond to a bioterrorist attack received an abysmal grade – 'F'. This is entirely unacceptable, especially when we have the solutions.  We have next generation medical countermeasures for anthrax that are languishing without adequate funding to ensure their procurement; we have leaders like Senators Graham and Talent, and many others, who are passionately dedicated to preventing WMD proliferation and terrorism.  As the Report Card makes clear, we need increased funding, more accountability, and less fragmented decision-making.   We have the answers and the solutions—it is imperative that we execute.  PharmAthene is committed to working with our partners in government to implement the solutions, and applauds Senators Graham and Talent for their leadership and dedication to this cause.

SOURCE PharmAthene


'/>"/>
SOURCE PharmAthene
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
2. Implicit Awarded US $16.3 Million U.S. Government Contract to Develop Immunomodulatory Drug for Biodefense Threats
3. HHS Secretary Leavitt Announces Members of the National Biodefense Science Board
4. Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board
5. Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference
6. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
7. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
8. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
9. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
10. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
11. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology:
(Date:8/23/2017)... 2017  The general public,s help is being enlisted in what,s thought ... in and on the human body –and are believed to affect health.  ... The Microbiome Immunity Project is the ... with the gut. The project's goal is to help advance scientific knowledge ... ...
(Date:6/23/2017)... N.Y. , June 23, 2017  IBM (NYSE: ... dairy research, today announced a new collaboration using next-generation ... chances that the global milk supply is impacted by ... Cornell University has become the newest academic institution to ... a food safety initiative that includes IBM Research, Mars, ...
(Date:5/16/2017)... , May 16, 2017   Bridge Patient ... organizations, and MD EMR Systems , an ... partner for GE, have established a partnership to ... product and the GE Centricity™ products, including Centricity ... These new integrations will allow ...
Breaking Biology News(10 mins):